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ABSTRACT
Fibromyalgia is a nonarticular rheumatic disease of unknown origin. It is
diagnosed by the presence of widespread pain of more than three months
duration and tenderness at 11 or more of 18 tender point sites. Typical
symptoms of this syndrome are generalized pain, stiffness, and chronic fatigue
due to sleep disturbances. Other uncommon symptoms include headaches,
anxiety, depression, irritable bowel syndrome, and numbness. These
symptoms become worse with the presence of modulating factors such as
weather, stress, fatigue, overexertion, or inactivity.
The purposes of this independent study are to examine the prevalence
and demographics of this disorder, discuss the etiology and pathophysiology,
list common symptoms, and present diagnostic criteria that have been proposed
in the literature. In addition, suggestions will be provided on how to best
manage this disorder.

vi

CHAPTER I
INTRODUCTION
Fibromyalgia is a frequently occurring disorder in the outpatient physical
therapy population. 1 Fibromyalgia syndrome is defined as a form of
nonarticular rheumatism with chronic, diffuse musculoskeletal aChing. 2 It is
3

often associated with poor sleep, fatigue, and morning stiffness.

These

symptoms are aggravated by factors such as the weather, physical or mental
stress, physical exertion, and poor quality sleep.2 Age is not a determining
factor in the diagnosis of fibromyalgia.
Age at onset is difficult to determine because these patients have
typically been seen in the clinic for a multitude of musculoskeletal disorders,
including a number of rheumatic conditions. 4 The onset of fibromyalgia may
occur at any age, but the highest incidence is during middle age. The age of
onset ranges from nine to 55 years of ageS with the most common age of onset
occurring between 35 and 50 years of age. S-11
Five types of onset are described in the literature. 4 They include:
(1) onset in childhood; (2) onset in adult life with a history of severe
musculoskeletal complaints; (3) insidious onset in adult life; (4) onset following
infection, surgery, or other event; and (5) onset following trauma. A few

1
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patients will report the beginning of their symptoms after experiencing a
traumatic event, but the majority of patients will not be able to recall any prior
event that can readily be identified as the cause of their pain. 6 No matter what
the onset, the course of the syndrome continues in a chronic manner with little
hope for remission.
Several studies show that fibromyalgia follows a chronic course. One
study gave a four-year follow-up survey to patients with fibromyalgia. 12 This
study showed that 72.3% of patients reported an increase in pain, 15.7%
reported no change in condition, and 9.6% reported improvement or no pain at
the end of the four-year period. Another study13 surveyed 39 fibromyalgia
patients annually, with initial contact on average of 1.3 years after diagnosis.
Throughout three surveys, more than 60% of patients reported moderate to
severe continuing symptoms. By the third survey, 97% still reported pain and
62% claimed moderate to severe morning tenderness. Only 3% experienced

complete remission. The researchers concluded that fibromyalgia is a chronic
disease with symptoms lasting at least three years after diagnosis with a very
small chance for remission.
Similar results have been reported by Wolfe. 14 At a follow-up evaluation
at least a year after diagnosis, 90% of patients continued to complain of pain
and 100% had chronic musculoskeletal pain.
Another study by Wolfe 4 questioned 81 patients with fibromyalgia and
revealed that 23% of patients had periods of two months or greater without

3
symptoms. The mean length of the disease for these patients was 12.7 years
and the mean length of remission was 34 months (approximately 21 % of the
disease course). Therefore, the majority of the time spent in this disorder is in
the active, painful state.
Historical Review
The history of how the diagnosis of fibromyalgia evolved is interesting
because it spans hundreds of years. Researchers do not know exactly how
long this syndrome has been afflicting humans. There are references to pain,
exhaustion, and disturbed sleep, common features of fibromyalgia, as far back
as in the Old Testament of The Holy Bible (Job 7:3-4, Job 30:16-17, Psalms
6:2-6).15 Despite an apparently long period in which symptoms have been
reported, this condition was not fully recognized until the 1700s.
In the 1700s, German physicians divided rheumatism into two categories:
articular and muscular. Articular rheumatism was associated with pain and
stiffness in the joints and muscular rheumatism was described as a disease of
the muscle associated with hardening or nodules. During approximately the
same time frame, physicians in Great Britain began to characterize muscular
rheumatism as a disorder of connective tissue rather than of muscle. In 1815,
William Balfour was the first to postulate that the nodules located in muscle
were caused by connective tissue inflammation. 16 Sir William Gowers
introduced the term fibrositis in 1904.17
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Gowers developed the term "fibrositis" based on his belief that
inflammation was the primary etiological factor involved in this syndrome. 17 He
believed that sciatica was due to an inflammatory process involving the nerve.
He rationalized that because lumbago (a type of muscular rheumatism) often
caused sciatica, lumbago (and other types of muscular rheumatism) must be
inflammatory as well. He thus called a variety of musculoskeletal conditions
involving inflammation "fibrositis." For years, fibrositis was used to describe a
plethora of pain disorders and non-specific musculoskeletal aching. 2
Ralph Stockman,18 also in 1904, published a study stating that the painful
nodules associated with chronic rheumatism may be caused by connective
tissue hyperplasia or inflammation of the perimysium. He noted these nodules
were most common in the fibrous ligaments of the joints, the musculotendinous
junctions, and in the fibrous tissues of muscles, bones, or jOints. He listed
several factors capable of aggravating this condition, including cold and damp
weather or muscle exertion. Because of Gowers' and Stockman's studies,
inflammation was blamed as the cause of muscular rheumatism for years.
In the 1940s, researchers discovered there was no presence of
inflammation in the connective tissue of patients with fibrositis. 16,19 This made
the term fibrositis a misnomer because "-itis" implies inflammation. 20 Henctf° in
1976 proposed the term ''fibromyalgia'' to describe this syndrome. Fibromyalgia
is currently the preferred name for widespread nonarticular pain and its use is
endorsed by the American College of Rheumatology (ACR).11
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In the past, fibromyalgia was divided into two categories: primary and
secondary/concomitant. Primary fibromyalgia was defined as that which
occurred for unknown reasons and did not occur with any other musculoskeletal
disorder. Secondary/concomitant fibromyalgia occurred in patients with other
musculoskeletal or medical problems that mimicked the symptoms of
fibromyalgia. 4 These classes made the diagnosis of fibromyalgia confusing and
subjective to the examiner. 4 The position of the ACR is that primary and
secondary/concomitant categories are not easily separated in a clinical setting.
Therefore, the classifications of primary and secondary fibromyalgia should be
abolished. 11
Prevalence and Demographics
The exact prevalence of fibromyalgia in the rheumatologic practice and
the community is not known. Fibromyalgia is estimated to be the third most
common rheumatic disorder after osteoarthritis (OA) and rheumatoid arthritis
(RA).9 The greatest prevalence of fibromyalgia is found in rheumatology clinics,
with a rate of approximately 15-20%.5,9 The prevalence of fibromyalgia is less
in general medical clinics, with a rate of 3.7%? There are no studies regarding
the prevalence of fibromyalgia in the community.4
The demographics of this disorder are not specific except for gender.
Research has shown that more than 70% of the patients with fibromyalgia are
female. 5,7,9,11 Studies have shown that the average patient with fibromyalgia has
a slightly higher educational level and earns slightly more than the typical U.S.
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citizen. Patients with fibromyalgia have a higher rate of marriage than the
normal population. 8 ,21 These data do not point out a specific demographic
factor, or combination of factors, that could identify a patient with fibromyalgia
from the general population. Therefore, it does not appear that demographics
contribute to the etiology of this disorder.
The chapters that follow wi" describe common symptoms associated with
this syndrome, present diagnostic criteria that have been proposed in the
literature, and discuss theories related to etiology and pathophysiology. In
addition, suggestions wi" be presented on how to help manage this disorder.

CHAPTER II
SYMPTOMATOLOGY AND DIAGNOSTIC CRITERIA
The most common symptoms associated with fibromyalgia include
chronic fatigue due to sleep disturbances, stiffness, and generalized
pain. 5 ,6,8,11,21,23 Fatigue, severe enough to disturb ADLs, is a universal
complaint. 23 Sleep disturbances, such as intermittent sleep, early morning
awakenings, and non-restorative sleep, were reported by 56% to 90% of
patients. 5 ,11,24 Poor sleep is believed to contribute to the stiffness associated
with this syndrome. The general stiffness of fibromyalgia is typically most
noticeable in the morning and does not decrease with activity.23 The pain
associated with this syndrome is characterized by chronic, diffuse,
musculoskeletal aching and soreness21 in the proximal musculature, such as
the neck, shoulders, elbows, knees, hips, and back.23 The right side is usually
more affected than the left. 8
Although the predominant symptoms of fibromyalgia are fatigue,
stiffness, and pain, these are not the only symptoms capable of causing
discomfort. The individual with fibromyalgia may also suffer from one or more
of the following problems: recurrent headaches, irritable bowel syndrome,
hypersensitivity to heat or cold, anxiety, depression, numbness in the hands or
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feet, menstrual disturbances, subjective swelling, abdominal pain, and reticular
skin discolorations. 5,7,8,11,21,24,25
The symptoms of fibromyalgia apparently become worse with the
presence of various modulating factors. These factors include cold and humid
weather, weather changes, fatigue, overexertion, repetitive motion, emotional
stress, caffeine, poor sleep, anxiety, air conditioning, and inactivity.7,11,14,16,26,27
The symptoms of fibromyalgia may become severe enough to create
problems at the work place and in the performance of activities of daily living
(ADLs). A correlative relationship has been identified between patients'
perceived status of their disorder and their ability to work. The work status of
176 patients with fibromyalgia were examined. 22 Of the entire 176 patients in
the study, 54% were employed, 30% had changed jobs due to the limitations of
fibromyalgia, and 17% had stopped working due to the disease. Of those of
working age (18-65 years old), 9.6% considered themselves disabled and 6.2%
of this group received disability payments for musculoskeletal disorders.
However, none of those were receiving disability compensation for the specific
diagnosis of fibromyalgia. This study demonstrated that most patients with
fibromyalgia are able to work even though it may be necessary to change their
jobs in order to do so.
Patients with fibromyalgia are not as productive as their unaffected
counterparts. Twenty-eight patients with fibromyalgia were evaluated and
compared to 26 individuals with RA and 11 normal controls in the performance
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of five standardized work tasks.22 It was found that fibromyalgia patients
performed 58.6% as much work as the normal controls and RA patients
performed as much as 62.1 % of the controls. The ability to work was related to
functional disability, psychological status, and pain. The strongest indicator of
work performance was a self-assessed disability index.
In the same study, it was found that patients with fibromyalgia reported a
significant time lost from work.22 Of those who were employed, the average
time lost in six months was approximately five days. Fewer than nine percent
lost more than seven days. Non-working patients reported that they were not
able to perform ADLs an average of 12.6 days in a six-month period and 31 %
were not able to function for more than seven days in the same time frame.
The patient with fibromyalgia may expect to experience lost wages and
compensation as a result of time lost from work.
In spite of the presence of characteristic symptoms and a history of
inability to perform at work or complete ADLs, the diagnosis of fibromyalgia is
difficult to make. One reason diagnosis is difficult is because fibromyalgia is
poorly recognized by the medical profession. s Several years may pass
between the onset of symptoms and correct diagnosis. 6 Patients will continue
to see one health care professional after another in the hope of receiving a
correct diagnosis. Failure to correctly make the diagnosis of fibromyalgia leads
to considerable physical, mental, and financial drains for the patient. After time,
patients may start to believe they are hysterical, hypochondriacal, or
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malingering. 28 In order for an effective treatment regime to begin, the correct
diagnosis needs to be made. The correct diagnosis depends on an accurate
history and physical exam of the patient. 29
The first step leading to the diagnosis of fibromyalgia is a detailed history
from the patient and a physical examination. The patient's history will usually
reveal a report of having received several medications and modalities without
experiencing any noticeable changes in his or hercondition. 6 The most
prominent findings of the physical examination are the lack of any specific
objective information. The musculoskeletal examination reveals no swelling or
tenderness,29 no soft tissue edema, no loss of range of motion, and no true
muscle weakness. 23 The laboratory reports are negative as well. There are no
hematological, serological, histological, or radiological abnormalities. 30 The
patient appears to be in fair general health. 23
Overall, the diagnosis of fibromyalgia is based on the presence of
chronic musculoskeletal pain and reproducible tender points. 3 Tender points
are the single most distinguishing feature of fibromyalgia. A tender point is a
localized'area where slight to moderate pressure creates a reproducible painful
sensation. 19,23 Tender points are usually located in symmetry at typical
locations. 23 The most common sites are at the tendino-osseous junctions and
fat pads of the neck, shoulder, low back, and pelvic areas. 30 The presence of
tender points is a critical factor in the diagnosis of fibromyalgia.
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Throughout the years, tender points have remained a common factor in
the search for a proper diagnostic criteria for fibromyalgia. All studies agree
that fibromyalgia patients have a decreased tolerance to pain over tender
points, but studies differ in the number of tender points required for

y2

diagnosis. 5 ,9,31 Smythe and Moldofsk

in 1977 were the first to propose

diagnostic criteria for fibromyalgia. The criteria for fibromyalgia have since
been revised several times. The most current diagnostic criteria were
developed by the Multicenter Criteria Committee headed by Wolfe et al 11 and
adopted by the ACR in 1990.
The current criteria were developed upon examination of 293 patients
with fibromyalgia and 265 controls. The controls were age and sex matched
with neck or low back pain syndromes, local tendinitis, trauma related pain
syndrome, possible systemic lupus erythematosus (SLE), or possible RA.
Using the data gathered from these subjects, fibromyalgia was defined as
widespread pain (pain above and below the waist and on both sides of the
body) with a duration of more than three months. In addition, tenderness at 11
or more of 18 tender point sites must be present. The tender points used for
the examination are listed in Table 1.
The ACR criteria are regarded as the most sensitive, specific, and
accurate to date. The criteria of widespread pain and tenderness at 11 of 18
tender points has a sensitivity, or true positive rate, of 88.5% and a specificity,
or true negative rate, of 81.1 %.11 This is better than any other previous
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Table 1.--Tender Point Sites
Occiput: at the suboccipital muscle insertions.
Low cervical: at the anterior aspects of the intertransverse spaces at CS-C 7 •
Trapezius: at the midpoint of the upper border.
Supraspinatus: at origin above scapular spine near the medial border.
Second rib: at the costochondral junctions.
Lateral epicondyle: 2 cm distal to the epicondyles.
Gluteal: in the upper outer quadrants.
Greater trochanter: posterior to trochanteric prominence.
Knee: at the medial fat pad proximal to the joint line.
(All the above points are bilateral.)
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diagnostic criteria. Even though a consensus has been reached regarding the
diagnostic criteria for fibromyalgia, the diagnosis may still be difficult to make or
may be missed entirely.
Diagnosis is difficult as fibromyalgia can mimic a variety of conditions or
illnesses. For this reason, it is necessary to perform a differential diagnosis.
The following conditions need to be ruled out before a definitive diagnosis of
fibromyalgia is made: early RA, early SLE, chronic fatigue syndrome,
polymyalgia rheumatica, hypothyroidism, osteoarthritis, psychogenic
rheumatism, early ankylosing spondylitis, or myofascial pain syndrome. 5,3o
Of all the similar differential diagnoses, myofascial pain syndrome and
fibromyalgia are the most difficult to differentiate. These syndromes have
several characteristics in common and may represent two extremes of the
same disorder, even though they are regarded as two distinct clinical entities. 16
Myofascial pain syndrome is defined by some as any regional soft tissue
disorder and by others as a form of localized fibromyalgia; there currently is no
consensus on the definition of myofascial pain syndrome. 33 In its simplest form,
myofascial pain syndrome consists of an acute onset of pain in one muscle
following trauma to that muscle. 16 Myofascial pain syndrome is generally more
localized than fibromyalgia. However, it may involve multiple sites, cause
systemic symptoms, become chronic, and eventually develop into
fibromyalgia. 14,29 In contrast, fibromyalgia is chronic, widespread, and systemic
in nature from onset. 14
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The major distinguishing feature between these two syndromes is the
presence of tender points and trigger points.14 As previously described, tender
points are the major criteria for the diagnosis of fibromyalgia. Tender points are
typically located at the attachment of muscle to bone or over fat, tendon, or
aponeurosis. Pain referral is not characteristic of the tender points found in
patients with fibromyalgia. 16 Trigger points are characteristic of myofascial pain
syndrome and are defined as painful areas of soft tissue and taut bands of
muscle that produce radiating pain spontaneously or following pressure.
Trigger points are located in the muscle belly and may also cause paresthesias
or autonomic symptoms. 1,6,16,30
In summary, the most common symptoms of fibromyalgia are chronic
fatigue due to sleep disturbances, stiffness, and generalized pain. Other less
common symptoms include paresthesias, chronic headaches, and anxiety.
Symptoms become worse with the presence of modulating factors such as
changes in the weather, physical or mental stress, and poor sleep. The major
distinguishing characteristic of fibromyalgia is the presence of tender points.
The presence of tender points has led to the establishment of specific
diagnostic criteria adopted by the AeR. The development of diagnostic criteria
has made it possible to perform research on fibromyalgia which has led to the
evolution of several theories related to its etiology.

CHAPTER III
ETIOLOGY AND PATHOPHYSIOLOGY
Early research by Gowers 17 and Stockman18 implicated histological
abnormalities in affected muscles as potential causes of fibromyalgia.
However, these reports and others prior to 1980 cannot be correctly interpreted
because they included a multitude of other conditions in their diagnostic criteria.
With clearer diagnostic criteria, research has been easier to interpret, but still is
inconclusive in regard to the etiology of this disorder. 3 The current theories
regarding the etiology and pathophysiology of fibromyalgia involve muscle
abnormalities, pain perception, psychological factors, neurochemical
imbalances, and sleep disturbances.
Muscle Abnormalities
It has been proposed that skeletal muscle is the cause of the diseaseprocess associated with fibromyalgia. Changes in muscle metabolism,
contraction and spasm, and the tissue itself have been studied. However,
biochemical, histological, electromyographic, and radiographic research is
inconclusive in its evidence regarding fibromyalgia. 34-38
It may be possible that muscle hypoxia contributes to the pain associated
with fibromyalgia. 34 Biopsy samples taken from painful tissue have shown
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decreases in adenosine triphosphate, adenosine diphosphate, and phosphoryl
creatine and increases in adenosine monophosphate and creatine. 24 Chemical
changes occurring during energy metabolism may be due to a defective
synthesis or an increased rate of breakdown of the metabolites. While muscle
hypoxia may be the factor leading to the altered metabolism, this has not been
established. Regardless, the study shows real metabolic changes in painful
muscles and supports the hypothesis that pain is of muscular origin.
Fibromyalgia pain of a muscular origin is supported by other researchers.
One study35 observed that the muscle fibers of fibromyalgia patients are
connected by reticular or elastic fibers which pull neighboring cells when an
adjacent cell contracts. This creates a passive sideways stretch or pull which
may cause pain or multiple contractions, leading to muscle exhaustion and pain.
This study also concluded skeletal muscle is involved in fibromyalgia pain.
Electromyographic studies, however, do not implicate skeletal muscles as
a pathophysiological factor. Needle electromyography (EMG) has been
performed to determine if spontaneous activity or motor unit activity is present
in patients with focal myofascial pain or fibromyalgia. 36 Trigger points, tender
points, and palpable muscle bands were examined. These sites were found to
have normal EMG patterns at rest and with a voluntary muscle contraction. No
electrodiagnostic evidence of denervation or spasm was found with focal
myofascial pain or fibromyalgia. Full motor recruitment was present in all
muscles tested. The authors concluded that palpable muscle changes were not
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associated with increased electrical activity; something other than muscle
contraction must be the cause of the symptoms. A similar study 37 also found a
lack of electro myographic evidence to prove that tender areas are in a state of
spasm. EMG analysis of 16 patients found that all areas of so-called muscle
spasm were electrically silent. These two studies contradict the pain-spasmpain hypothesis and show that skeletal muscle is not affected in patients with
fibromyalgia.
Magnetic resonance imaging also has failed to detect skeletal muscle
abnormalities. 38 Tender points within the trapezius and suboccipital
musculature of patients with fibromyalgia were examined. No abnormalities,
edema, or inflammation in the soft tissue or underlying bone were found. This
study shows that skeletal muscle may not be the cause of the symptoms
associated with fibromyalgia.
Pain Perception
It has been proposed that fibromyalgia is due to faulty pain perception. 39
Pain is thought to be magnified in patients with fibromyalgia. The pain
thresholds and pressure pain tolerances on the deltoid and tibia were compared
in 46 females with fibromyalgia and 50 healthy controls. 41 Subjects with
fibromyalgia were found to have lower pain thresholds and lower pain
tolerances than. the control group. In addition, fibromyalgia patients typically
describe their pain with more pain adjectives and describe more diffuse and
burning pain than patients with RA. 40
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Fibromyalgia has been referred to as a "pain amplification syndrome"
with exaggerated tenderness at specific sites. 31 Because the tender sites are
not located exclusively in muscles, the pain must not be caused by any
pathologic or pathophysiologic disorder of the muscles. Tender spots may be
caused by any disorder of pain modulation. Factors such as poor sleep, cold
exposure, and pain referred from deep structures are all capable of causing a
general amplification of pain and tender spots.
Pain modulation impairments in the central nervous system (CNS) may
alter pain perception. First, there may be a lack of inhibition of painful stimulL 42
Second, the disorders in pain modulation cause an increase in the sensitization
of the muscle nocioceptors. Increased sensitization begins with a disturbance
in the muscular circulation. 19 Microcirculation may .be affected by factors such
as incomplete relaxation between muscle contractions or decreased blood flow
during work. The decrease in microcirculation causes sensitization of muscle
nocioceptors and results in pain at rest. Pain at rest can stimulate activation of
the deep pain system causing peripheral sensitization. Persistent peripheral
stimulation results in sensitization of pain neurons in the CNS. The
sensitization makes it possible for low threshold stimuli to activate the pain
system or allows spontaneous activity to occur in the nocioceptive nerves.
Fibromyalgia may be caused by disorders in pain modulation. Individuals
with fibromyalgia have been found to have decreased pain thresholds and pain
tolerances as compared to normal controls. This finding has led to the belief
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that disorders in pain modulation in the eNS may be the cause of fibromyalgia.
The disorders in pain modulation causing hyperalgesia may occur as a result of
abnormal levels of neurochemicals in the eNS.
Neurochemical
The role of a metabolic or neuroendocrine abnormality in the etiology of
fibromyalgia has been implicated for the past 15 years.43 There may be an
imbalance in the biochemical control of neural transmission in the brainstem,
dorsal horn of the spinal cord, peripheral neNes, or autonomic system. 30
Substances that have been proposed to cause symptoms are serotonin,
tryptophan, and Substance P.
Serotonin is a neurotransmitter in the eNS needed for the regulation of
deep, restorative sleep and the interpretation of painful stimuli. Serum levels of
serotonin have been shown to be lower than normal in patients with
fibromyalgia. 15 ,43 Plasma levels of tryptophan, an amino acid precursor of
serotonin, have also been found to be deficient in these patients. 3o •43 The low
levels of serotonin and tryptophan may explain the sleep disturbances and
hyperalgesia in patients with fibromyalgia.
The relationship of Substance P to the function of the neNOUS system
has also been studied. Substance P is a neuropeptide thought to aid in the
transmission of nocioceptive information. 15 Substance P dampens the
discharges of sensory neNes when the level of serotonin is normal. If
serotonin is deficient, it is unable to provide control over the neNes.43
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Theoretically, this results in an exaggerated response to normal stimulL 15
Serum levels of Substance P have been found to be elevated in the cerebral
spinal fluid of patients with fibromyalgia. 15 ,3o,43 The combination of decreased
serotonin and increased Substance P is believed to result in an exaggerated
perception of normal sensory stimulL 43 It also suggests that pain and sleep
disorders associated with fibromyalgia are both related to serotonin deficiency
and occur at the same time, rather than one causing the other. 43
Abnormalities in the function of neurotransmitters, such as serotonin,
tryptophan, and Substance P may cause many of the symptoms of
fibromyalgia. Abnormal levels of these substances may contribute to the sleep
disorders and increased sensitivity associated with this disorder. A better
understanding of these neurochemicals will aid in the development of an
effective treatment for this disorder.
Psychological Factors
The conflicting evidence regarding a pathophysiological explanation has
led to the consideration of a psychological cause. Fibromyalgia has been
considered to be a type of conversion or somatization disorder.44 However,
there is no concrete evidence that fibromyalgia is caused by any psychiatric or
psychological factors. 19
Studies have not found any relationship between psychological disorders
and fibromyalgia. The National Institute of Mental Health's Diagnostic Interview
Schedule was given to 31 fibrositis patients, 14 RA patients, and four controls. 44
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An association of depression with fibromyalgia was found, but it was not a
causal relationship. The conclusion reached was that the majority of patients
with fibromyalgia do not have psychopathology and are not likely to benefit from
high doses of antidepressants or psychotherapy.4o
In addition, a similar study45 found no difference between patients with
fibromyalgia, patients with RA, or controls with regard to frequency of lifetime
diagnosis of any psychiatric disorder, such as major depression or anxietybased disorders. The patients with fibromyalgia did not show a more significant
history of depression than RA patients or controls.
From these studies, it appears that fibromyalgia is not caused by any
psychological factor. If a patient does experience psychological problems, it is
more likely that these problems occur as a result of fibromyalgia rather than
cause it. 19
Sleep Disturbances
Abnormal sleep patterns seem to be the most commonly accepted
etiology for fibromyalgia. 15 The common theme of sleep disturbances was
demonstrated in a survey in which 95% of patients with fibromyalgia complained
of waking tired, 100% complained of waking with aching and stiffness, and

100% complained of feeling tired throughout the day.13 Since there is almost
universal occurrence of a sleep disturbance, it appears that sleep may be a
substantial factor in the etiology of fibromyalgia. However, the role of sleep
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disturbance as a causative factor is not entirely clear. Researchers do not
know if it is a primary or secondary pathogenic factor. 4o
Moldofsky and co-workers 46 were the first to show that sleep
disturbances are capable of producing fibrotic tender points in normal
volunteers. Patients with fibrositis syndrome and healthy subjects undergoing
Stage 4 sleep deprivation were studied. Both groups showed alpha rhythms in
non-rapid-eye-movement (NREM) sleep. Alpha activity in NREM sleep normally
accounts for about 20% of sleep; in fibromyalgia patients, this ratio may be as
high as 60% to 80%.40 During the experiment, the healthy subjects undergoing
sleep deprivation showed alpha rhythms in NREM sleep and they experienced
temporary musculoskeletal symptoms, mood disturbances, morning stiffness,
and increased point tenderness similar to those of the fibrositic patients.
An especially interesting finding of this study was that patients who were
physically fit and maintained their level of exercise throughout the study
experienced no symptoms or increased tenderness while deprived of sleep.
This finding is significant because it indicates that exercise may help prevent
this condition or it may help to control the symptoms if already present. This
point will be discussed in further detail in the chapter on management.
These studies suggest the presence of an internal arousal system,
triggered by trauma or disturbing emotional problems, causing alpha wave
intrusion into normal delta wave Stage 4 sleep. This may increase fatigue,
anxiety, and musculoskeletal aching. These factors may perpetuate the
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disturbed sleep cycle. Moldofsky46 doubts that sleep disturbance is the primary
cause of fibromyalgia, but it likely plays a role in perpetuating the symptoms.
Therefore, successful treatment may lie in improving sleep physiology.
Throughout the years, many hypotheses have emerged regarding the
etiology of fibromyalgia. Research results show that there is conflicting
evidence regarding the etiology. It appears that there is no single etiological or
pathophysiological factor that produces a causal relationship. Instead, several
factors may interact to produce the symptoms of fibromyalgia. Further research
is needed to determine the specific cause of fibromyalgia. Until this evidence is
produced, the treatment of this disorder will continue to be a process of trial
and error.

CHAPTER IV
MANAGEMENT
Voltaire describes the art of medicine as the ability to keep the patient
entertained while the disease runs its inevitable course. 47 This quote seems to
perfectly describe the treatment effort applied to patients with fibromyalgia. The
patients undergo physical, pharmacological, and sometimes psychological
therapy in order to find a successful way to manage the symptoms of their
disorder. Treatment has been found to be the most effective in patients who
have been diagnosed correctly. The longer the symptoms have been present
and the longer a person has been suffering from a state of chronic pain, the
less the chance of response to treatment and recovery.21,37
The goals of treatment are to provide patients with a means to manage
their musculoskeletal pain, to decrease the severity of their symptoms, and to
eliminate their dependence on medical services. 14,16 Several options for the
treatment of fibromyalgia exist. These include aerobic conditioning,
acupuncture, transcutaneous nerve stimulation (TENS), biofeedback, and
psychotherapy. Medications have also been attempted to control the
symptoms. 1,40 A typical program of treatment involves patient education,
medication, physical therapy, and exercise.
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Patient Education
Following diagnosis, the first step in the treatment of fibromyalgia is to
educate and reassure the patient. 16 It is helpful to include friends and family
members in this process as their support is extremely important. The etiology
and course of the disease should be thoroughly explained along with symptoms
the patient might experience. This information could be included in an
educational brochure.
Patients should be informed of the chronic nature of this syndrome and
must understand that even though there is no cure for this syndrome, there are
ways in which they can control their pain and increase physical functioning.
The education process should stress the importance of active patient
participation in the treatment program to discourage dependence on the
therapist or on any passive modalities. 23 ,48 The patient needs to be taught to
avoid potential exacerbating factors, such as stress, anxiety, and overexertion.
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Patients should recognize that changes in lifestyle and job may be
necessary to decrease physical and mental stress. 5 These changes should
encompass body mechanics, posture, and ergonomics. Rest and relaxation are
necessary at work and at home. Several short breaks should be taken
throughout the day to change posture and decrease static muscle loading.
Stretching exercises can be performed during the breaks. By making these
changes, the individual with fibromyalgia is more likely to be able to perform his
or her tasks at home or in the work place.
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Medications
There is no single "miracle drug" capable of eliminating the symptoms of
fibromyalgia. However, a group of drugs known as the tricyclic agents are
capable of decreasing symptom severity.21 The success of the tricyclics is
based on the premise that the etiology of fibromyalgia is caused by a sleep
disturbance. 46
The tricyclics function primarily by increasing serotonin which helps to
induce a deeper sleep and prevent early morning awakening. 24 ,42 The patient
benefits from increased quality and quantity of sleep.23 The tricyclics also have
indirect muscle relaxant properties; they decrease motor neuron efferent activity
at a supraspinal level. 40 The most commonly used tricyclics are amitriptyline
(Elavil) and cyclobenzaprine (Flexeril).16,23,24,40
Amitriptyline and cyclobenzaprine have the basic structure of the tricyclic
antidepressants and have a similar method of action. 43 Amitriptyline has
antidepressant properties in high doses, but in low doses it is effective at
improving sleep, relaxing muscles, and producing analgesia. 25 By improving
sleep, it indirectly improves mood and decreases pain. 42 Cyclobenzaprine is a
tricyclic similar to amitriptyline, but has minimal antidepressant effects. 49 It
functions primarily as a muscle relaxant 40 and is mildly effective at treating this
disorder. 23 ,49 Amitriptyline is usually preferred to cyclobenzaprine.
Non-steroidal anti-inflammatory drugs (NSAIDS) such as ibuprofen and
naproxen are typically used to decrease inflammation and produce analgesia.
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Since inflammation is not present in this disorder, NSAIDS are of limited value
in fibromyalgia treatment. 16,24,30 However, they may be helpful at decreasing the
severity of pain at local areas and relieving chronic pain and stiffness. 23 ,3o
A study comparing the effects of the tricyclics and NSAIDS found
amitriptyline to be more effective than naproxen, but naproxen was more
effective than placebo. The most effective therapy was the combination of both
drugs, which gave an additive benefit. 43 Similar enhancement by an NSAID
was noted in a study comparing alprazolam and ibuprofen for the treatment of
fibromyalgia. 50 Alprazolam is a benzodiazepine derivative with anxiolytic and
antidepressant effects. It has similar properties to amitriptyline and is better
tolerated 43 but more addictive. 30 The greatest improvement in pain and in the
patient rating of disease was with the ibuprofen and alprazolam group as
compared to the ibuprofen and placebo, alprazolam and placebo, and double
placebo groups.50
Physical Therapy
Patients diagnosed with fibromyalgia are often referred to a physical
therapist. A physical therapist is a health professional trained in the use of
modalities, stretching and strengthening principles, cardiovascular exercises,
and methods to restore muscle and joint mobility. The physical therapist will be
able to help the patient establish a program of exercise that can be carried out
independently.
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When a patient is first seen in physical therapy, the initial goal is to
decrease pain and relax tight muscles. This may be accomplished through the
use of moist heat, high intensity galvanic stimulation, progressive relaxation
training, or massage. The second goal is to teach the patient normal
neuromuscular functioning. Instruction in posture and body mechanics will help
to decrease stress placed on muscles. Gentle prolonged stretching will help
the muscle return to normal resting length. EMG biofeedback is useful to teach
the patient when muscles are contracting during postural movements. 16
Once a patient is seen for physical therapy, it is common for him or her
to overutilize this resource. Modalities are often used at the patient's request,
despite inadequate studies to prove their benefit. 30 Modalities, such as
massage, acupuncture, ultrasound, and electrical stimulation, exhibit only a
temporary effect at decreasing symptoms. 30 ,31 The only documented evidence
for the improvement of symptoms is with cardiovascular fitness training 47 ,51 and
EMG biofeedback. 52 Controlled studies utilizing other modalities need to be
done in order to justify their use. 40 Because dependence and overuse of
modalities eat up a large portion of the patients' health care budget, they should
only be used in the acute stage or in conjunction with an active exercise
program. 30
Exercise
Exercise as a possible treatment or preventor of fibromyalgia was first
proposed by Moldofskl6 in 1975. As previously discussed, this sleep
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deprivation study demonstrated difficulty producing tender points in participants
who were physically fit and were exercising at the time of the study. Therefore,
it was hypothesized that physical fitness, especially cardiovascular training, may
benefit patients with fibromyalgia.
Patients with fibromyalgia typically have decreased muscle tone and poor
physical fitness. 48•53 More than 80% of fibromyalgia patients scored below the
average level of fitness as based on statistics from age and sex matched
controls.
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It has been proposed that the chronic fatigue associated with this

syndrome results in a sedentary lifestyle and a decrease in the fitness level of
skeletal muscle. Consequently, the muscle is more susceptible to microtrauma
which produces the pain associated with the disorder. 53
Aerobic exercise benefits the individual in the following ways. It may:
(1) increase the resistance to microtrauma, (2) improve an individual's sense of
control over his or her body, (3) improve circulation within muscle,54 and
(4) improve mental attitudes. 48 It is believed that cardiovascular training may
decrease the symptoms of fibromyalgia through the activation of central or
peripheral beta-endorphin systems or the release of adrenocorticotropic
hormones (ACTH).54-56 During exercise, beta-endorphin is always co-released
with adrenocorticotropic hormone (ACTH).4 Elevated beta-endorphin levels
have been tied to changes in pain and affective ratings in long-distance
runners. Release of ACTH and cortisol occurs in response to any stress;
exercise greater than 60% of maximal oxygen consumption is considered to be
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a stress. The release of beta-endorphin, cortisol, or ACTH with exercise is
believed to cause the changes in pain ratings and mood experienced in people
who exercise. 54
Several studies have proven that aerobic exercise is beneficial. A
cardiovascular fitness training program was compared to a flexibility program in
patients with fibromyalgia. Two studies by McCain and colleagues47,52 showed
that a cardiovascular fitness program was superior to a flexibility program at
decreasing the symptoms of fibromyalgia. Patients in the cardiovascular group
reported the following changes after 20 weeks in the program: decreased pain
ratings, decreased level of disease activity, improvement in psychological
profiles, and improved cardiovascular fitness. These results were far more
significant than the results of the flexibility group. Neither group, however,
experienced a change in the percent of body area affected or improved sleep
disturbances. These findings suggest both types of exercise may decrease the
symptoms of fibromyalgia, but cardiovascular training produces better results.
Other studies54,57 have demonstrated similar results attesting to the benefits of
aerobic exercise, but results have not been as significant as McCain's.
A home program of exercise should be initiated early in the rehabilitation
program to prevent dependence on passive modalities. The home program
should include stretching, strengthening, and endurance exercises. To increase
compliance, the exercises should be simple and enjoyable and should not
necessitate major changes in lifestyle. The exercises should be demonstrated
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to the patient and be provided in written form. The exercise prescription should
include the number of repetitions, frequency, duration, contraindications, and
instructions for progression for all types of exercise.
There are several guidelines that should be considered in the
prescription of an exercise program. The exercise program should begin gently
and in the pain-free range. Activity should be continually increased but kept
within pain tolerance. Rest periods, if necessary, are important. 48 Exercises
that increase muscle tension, such as weight lifting, are not tolerated as well
and should be introduced gradually.25
In summary, the best treatment of fibromyalgia requires multiple
strategies including education, behavior modification, modalities, physical
conditioning, and a comprehensive approach to wellness. 40 •57 The patient
should be an active participant in the treatment program. The most significant
ways in which patients can help themselves are to: (1) become better
educated in the cause of fibromyalgia, (2) remain active and try to gain an
increased level of physical fitness, and (3) try to identify and eliminate
exacerbating factors. 58

CHAPTER V
CONCLUSION
Fibromyalgia is defined as a form of soft tissue or muscular rheumatism
primarily affecting muscles and their attachments to bones. Within the past two
decades, this syndrome has been recognized by rheumatologists as the third
most common rheumatic disorder after RA and OA. Fibromyalgia affects
millions of people in all walks of life, but generally occurs most frequently in
middle-aged females.
The exact cause of fibromyalgia is unknown. Several theories have been
proposed to explain the etiology and pathophysiology of this syndro-me including
muscle abnormalities, abnormal pain perception, psychological factors,
neurochemical imbalances, and sleep disturbances. Many different factors may
trigger fibromyalgia and produce the pain, fatigue, and sleep disturbances
associated with this syndrome. Triggering factors may include physical or
emotional trauma, inactivity, overexertion, poor sleep, and weather changes.
The most common symptoms of fibromyalgia are sleep disturbances,
stiffness, and generalized pain. Other symptoms that may be experienced
include headaches, abdominal pain, irritable bowel syndrome, hypersensitivity to
heat or cold, anxiety, depression, or reticular skin discolorations. Diagnostic
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criteria proposed by the American College of Rheumatology include widespread
pain (bilateral, axial, and above and below the waist) of more than three
months' duration and tenderness to palpation at 11 or more of 18 tender points.
In general, the most effective treatment program is one in which the
patient assumes an active role in the treatment program. Treatment is aimed at
providing the patient with a way to manage his/her musculoskeletal pain,
decrease severity of symptoms, and eliminate dependence on medical services.
With proper treatment, most people with fibromyalgia improve to some
degree and are able to live with their disease. However, more research is
needed to better understand the etiology of this syndrome. This research will
allow the development of a more effective treatment plan and possibly even
prevention of this disorder.
The current treatment program for fibromyalgia involves: (1) patient
education, (2) medications to improve sleep and decrease pain, (3) physical
therapy to normalize muscle tone and restore function, and (4) exercise to
increase cardiovascular fitness and strengthen muscles. The exercise program
should meet the needs of the patient and be designed specifically for each
individual.
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